Clinical Trial Technology and Digital Innovation

Clinical trial technology has become an integral part of modern clinical research, supporting how trials are planned, conducted, monitored and analysed.

Clinical-trial technologies can improve data collection, operational efficiency, participant engagement and oversight. Their successful implementation, however, requires appropriate attention to data quality, system validation, privacy, security, usability and regulatory requirements.

Table of Contents

Clinical Trial Technology: EDC and eSource

Electronic Data Capture (EDC) systems are widely used to collect and manage clinical-trial data through electronic case report forms.

EDC platforms can support:

Electronic data collection
Edit checks and data validation
Query management
Audit trails
User access controls
Data review
Database management

Clinical trials may also use electronic source data (eSource), where study information is originally recorded in electronic form.

Appropriate integration of eSource can reduce unnecessary transcription and facilitate more efficient data flow while maintaining traceability and data integrity.

Electronic Informed Consent

Electronic informed consent (eConsent) uses electronic technologies to support the informed-consent process.

Depending on the study, eConsent may incorporate:

Electronic consent documents
Multimedia information
Interactive educational material
Knowledge checks
Electronic signatures
Documentation of the consent process

Technology can improve accessibility and presentation of study information, but informed consent remains a process rather than simply an electronic signature.

Participants must have an appropriate opportunity to understand the study, ask questions and make a voluntary decision about participation.

Electronic Clinical Outcome Assessments

Electronic Clinical Outcome Assessments (eCOA) allow certain clinical outcomes to be captured electronically.

These can include:

Electronic patient-reported outcomes (ePRO)
Clinician-reported outcomes
Observer-reported outcomes
Performance outcomes

Electronic collection can reduce transcription and facilitate timely availability of data.

Systems and instruments should be appropriate for their intended use, and implementation should preserve the reliability and interpretability of the assessments.

Clinical Trial Technology for Decentralized and Hybrid Trials

Technology enables selected clinical-trial activities to take place outside conventional investigative sites.

Decentralized or hybrid approaches may use:

Telemedicine
eConsent
Remote assessments
Electronic questionnaires
Wearable technologies
Connected medical devices
Home health services
Remote data collection

Hybrid trials combine conventional site-based procedures with suitable decentralized elements.

These approaches can reduce participant burden and potentially improve trial accessibility, but require careful planning for investigator oversight, participant safety, technology support and data quality.

Wearables and Digital Health Technologies

Wearable sensors, connected devices and other digital health technologies can enable frequent or continuous collection of certain participant data.

Examples may include technologies that measure:

Physical activity
Heart rate
Sleep patterns
Mobility
Physiological parameters
Treatment adherence

Digital technologies can provide information that may not be captured during occasional site visits.

Before being used for important trial endpoints or assessments, technologies should be evaluated for their intended purpose, reliability and suitability for the study population.

The FDA provides recommendations for using digital health technologies to acquire data remotely from participants in clinical investigations in its Digital Health Technologies for Remote Data Acquisition in Clinical Investigations guidance.

Interactive Response Technologies

Clinical trials frequently use Interactive Response Technology (IRT) to support operational processes.

Depending on the trial, IRT systems may assist with:

Participant randomisation
Treatment assignment
Investigational-product supply
Inventory management
Site resupply
Blinding-related processes

Integration between IRT and other clinical systems can reduce duplicate data entry and improve operational efficiency.

Remote and Centralised Monitoring

Digital clinical-trial systems allow study information to be reviewed remotely and centrally.

Technology can support:

Centralised data review
Identification of unusual data patterns
Tracking of study metrics
Detection of missing information
Risk indicators
Targeted monitoring activities

Technology-enabled monitoring can complement on-site activities and support risk-based approaches to trial oversight.

Clinical Trial Technology Integration and Interoperability

Clinical trials increasingly use multiple technology platforms.

These may include:

EDC systems
Clinical Trial Management Systems
Electronic Trial Master Files
Safety databases
IRT systems
Laboratory systems
eCOA platforms
Imaging systems
Digital health technologies

Effective integration allows information to move between systems with less unnecessary manual intervention.

Interoperability, common data standards and well-defined interfaces can improve efficiency while supporting consistency and traceability.

Cloud-Based Clinical Systems

Cloud-based platforms are increasingly used to provide access to clinical-trial applications and data across geographically distributed research teams.

Potential benefits include:

Scalability
Centralised access
Collaboration
System integration
Remote working
More efficient technology deployment

Use of cloud technology in regulated clinical research requires appropriate controls for security, access, data protection, system availability and vendor oversight.

AI Trends in Clinical Trial Technology

Advances in clinical trial technology are increasing the exploration of artificial intelligence, machine learning and advanced analytics for selected clinical-research activities.

Potential applications include:

Patient identification and recruitment support
Data-quality review
Identification of unusual data patterns
Risk-based monitoring
Analysis of complex datasets
Medical-image analysis
Operational forecasting
Automation of selected repetitive activities

The use of these technologies should be appropriate for the intended purpose and supported by suitable governance, validation, transparency and human oversight.

Data Integrity and System Validation

Introducing technology does not remove the fundamental requirement for reliable clinical-trial data.

Electronic systems used in clinical research should support appropriate principles of data integrity, traceability and accountability.

Depending on the system and its intended use, controls may include:

Validation
Audit trails
User authentication
Role-based access
Change control
Backup and recovery
Documentation
Quality assurance

The level of control should be appropriate to the importance and regulatory relevance of the system and data.

Privacy and Cybersecurity

Technology integration increases the importance of protecting clinical-trial information and participant privacy.

Clinical research organisations should consider:

Data confidentiality
Secure data transmission
Access controls
Cybersecurity risks
Data storage
Third-party technology providers
Applicable privacy requirements
Incident-management procedures

Security and privacy considerations should be incorporated into technology planning rather than addressed only after systems have been deployed.

Participant Usability and Accessibility

A technology may function technically but still create problems if participants find it difficult to use.

Trial teams should consider:

Digital literacy
Accessibility
Device availability
Internet connectivity
Language requirements
Participant training
Technical support
Burden created by frequent digital interactions

Technology should support trial participation rather than create unnecessary barriers.

Regulatory and Quality Considerations

Clinical-trial technologies operate within existing ethical, regulatory and quality frameworks.

Sponsors and research organisations should evaluate applicable requirements relating to:

Good Clinical Practice
Electronic records and signatures
Data integrity
Computerised systems
Informed consent
Participant privacy
Digital health technologies
Clinical-trial monitoring
Vendor oversight

The specific requirements depend on the technology, its intended use and the jurisdictions in which the trial is conducted.

Future Trends in Clinical Trial Technology

Clinical trial technology is likely to become increasingly connected as digital health technologies, interoperable platforms, automation, advanced analytics and decentralized approaches continue to develop.

Technology should not be adopted simply because it is available. Its use should address a genuine scientific, operational or participant need while preserving participant protection and the reliability of trial results.

Successful technology integration therefore requires a balance between innovation, usability, data quality, regulatory compliance and sound clinical-research practice.

Professionals interested in developing broader knowledge of technology-enabled trial operations can explore ClinSkill’s Clinical Research Courses, covering key areas across the clinical trial lifecycle and practical clinical research processes.

You may be interested in…